The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Gabapentin Rosemont 50mg/ml Oral Solution

Taw Pharma (Ireland) LimitedPA23081/010/001

Main Information

Trade NameGabapentin Rosemont 50mg/ml Oral Solution
Active SubstancesGabapentin
Dosage FormOral solution
Licence HolderTaw Pharma (Ireland) Limited
Licence NumberPA23081/010/001

Group Information

ATC CodeN03AX Other antiepileptics
N03AX12 gabapentin


License statusAuthorised
Licence Issued26/10/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back